Fisher & Paykel Healthcare (OTCMKTS:FSPKF) Stock Price Up 8.8% – Should You Buy?

Shares of Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) traded up 8.8% on Wednesday. The stock traded as high as $28.09 and last traded at $28.09. Approximately 294 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 3,061 shares. The stock had previously closed at $25.8150.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Royal Bank Of Canada raised shares of Fisher & Paykel Healthcare from a “sector perform” rating to an “outperform” rating in a report on Tuesday, September 15th. Citigroup upgraded shares of Fisher & Paykel Healthcare to a “buy” rating in a report on Thursday, September 10th. Two investment analysts have rated the stock with a Buy rating. Based on data from MarketBeat, Fisher & Paykel Healthcare currently has a consensus rating of “Buy”.

Fisher & Paykel Healthcare Stock Performance

The business has a 50 day simple moving average of $25.95 and a two-hundred day simple moving average of $23.65.

Fisher & Paykel Healthcare Company Profile

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that develops, manufactures and markets products used in respiratory care, acute care and the treatment of obstructive sleep apnea. Its technologies are designed to support breathing, improve patient comfort and help healthcare professionals deliver respiratory therapies in hospitals, clinics and the home.

The company’s product portfolio includes respiratory humidification systems, heated breathing circuits, nasal high-flow therapy products, anesthesia and operating-room equipment, neonatal respiratory care products, and masks and related systems for sleep apnea treatment.